Engineered Microorganisms for High-Purity Glycine Fermentation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current industrial production of glycine is primarily through chemical synthesis from fossil-based precursors, which is environmentally harmful and inefficient, lacking an effective biological production method at industrial scale with sufficient purity and reasonable cost for agro-food and pharmaceutical industries.

Innovation Solution

Development of metabolically engineered microorganisms through genetic modification to overexpress glycine production pathways and suppress glycine degradation pathways, utilizing renewable carbon sources for efficient glycine production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If chemical synthesis from fossil-based precursors is used, then glycine production efficiency is high, but environmental harm increases and sustainability decreases

Engineering Contradiction:
Improveglycine production efficiencyVSAvoidenvironmental harm
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the fundamental parameter of raw material source from fossil-based chemical precursors to renewable biomass-based feedstocks. This parameter change enables glycine production through biological fermentation processes, maintaining high productivity while eliminating the environmental harm associated with fossil-based chemical synthesis and achieving sustainability through renewable resource utilization.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If chemical synthesis processes are used, then glycine can be produced at industrial scale, but purity requirements for agro-food and pharmaceutical industries are not met

Engineering Contradiction:
Improveindustrial scale productionVSAvoidglycine purity
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent extracts glycine from the complex metabolic system of genetically engineered microorganisms through selective fermentation processes. This extraction approach produces glycine in high-purity form suitable for agro-food and pharmaceutical applications while maintaining industrial-scale production capability, as the biological system naturally produces glycine free from the contaminants associated with chemical synthesis.

Inventive Principle:
Principle #2Taking out (Extraction)

3Object-affected harmful factors

If biological production methods are developed, then environmental impact is reduced, but production cost increases

Engineering Contradiction:
Improveenvironmental impactVSAvoidproduction cost
Core Design Contradiction:
Object-affected harmful factorsVSEase of manufacture

Solution Approach 1:

The patent employs genetically engineered microorganisms that self-convert renewable biomass feedstocks into glycine through their metabolic pathways. This self-service biological production system eliminates the need for complex chemical synthesis equipment and toxic reagents, reducing both environmental impact and production costs by utilizing naturally occurring biological processes that can be optimized through genetic engineering rather than expensive chemical infrastructure.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Biological production of glycine with reduced environmental impact and lower costs, meeting the purity requirements of agro-food and pharmaceutical industries.

Implementation Method 1

utilizing renewable carbon sources for efficient glycine production

Methodology Applied
Scientific EffectFermentation: Fermentation

Data Source

PatentUS20250361535A1Production of glycine by fermentation
Publication Date: 2025.11.27 LA SAS DYNVEO

AI summary

The present invention concerns a metabolically engineered microorganism for glycine bioproduction or a salt or an ester thereof, the genome of said microorganism comprises an attenuation of the expression of genes encoding enzymes having glycine cleavage system activity as defined by E.C. 1.4.1.27 together with an overexpressing of threonine dehydrogenase dependent pathway as defined by EC E.C. 1.1.1.103 and E.C. 2.3.1.29 and/or with a threonine aldolase dependent pathway as defined by E.C. 4.1.2.48 or EC 4.1.2.42 or any of its catalytically active variants, its use for the production of glycine or one of its salts or esters. The present invention also concerns a fermentation process using said metabolically engineered microorganism for the production of glycine or one of its salts or esters.